The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Basavalinga Sadasivaiah Ajaikumar & PACs
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. B.S. Ajaikumar, Promoter and Director of HealthCare Global Enterprises, sold 13,92,000 equity shares (about 1.00% of total share capital) through an open market block deal on August 20, 2025. Before the sale, his combined holding along with Persons Acting in Concert stood at 1,44,98,715 shares (10.40% of total, 10.28% of diluted capital). After the sale, the holding fell to 1,31,06,715 shares (9.40% of total, 9.29% of diluted capital). Voting-rights shares dropped from 6.84% to 5.84%, while encumbered (pledged) shares remained unchanged at 49,59,539 shares (3.56%). The filing was submitted under SEBI SAST Regulation 29(2), which is mandatory when a promoter crosses the 1% change-in-holding threshold.
Promoter selling 1% of equity through a block deal is typically seen as a mildly negative signal, as it may indicate the promoter is booking profits or rebalancing personal finances. However, the promoter and PAC group still retain a 9.40% stake, and the encumbered shares remain constant, so there is no distress signal. Shareholders may watch for follow-up block deals or further promoter trimming.